BT Imaging Founder Professor Thorsten Trupke to receive prestigious international photovoltaic industry award
BT Imaging Founder Professor Thorsten Trupke to receive prestigious international photovoltaic industry award Uniseed congratulates Professor Thorsten Trupke, Founder of Uniseed investee BT Imaging, who will be honored by the international scientific and...
Uniseed Investee Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema
First patient dosed with an investigational retinal vascular disease eye drop
Uniseed Investee Kinoxis Completes $5M Financing Round and Advances Lead Program Through Key Toxicology Studies
Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for substance use disorders and other central nervous system disorders, has completed a funding round of $5m to enable continued development of the company’s development programs.
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer reviewed academic journals
Research on preventative COVID-19 nasal spray published in prestigious, peer-reviewed academic journals: EBioMedicine and the European Respiratory Journal
Australian probiotic brand PERKii is excited to launch its new 100% plant-based Sparkling Probiotic Drinks into Coles Express stores nationally.
“The ultra-long range and massive capacity of our Wi-Fi HaLow technology along with its ultra-low-power is a game changer for the IoT.”
Uniseed has increased its stake in Australian biotechnology company Ena Respiratory which is developing a potentially landmark preventive treatment for COVID-19.
Uniseed Investee Morse Micro Announces an Additional US$13 Million Funding Round to Accelerate Wi-Fi HaLow
Latest investment takes total Series A funding to US $30 million to further develop its Wi-Fi HaLow technology and ramp customer designs
Leading custom compounder RTP Co. has acquired the patents for anti-scratch additives from Uniseed investee TenasiTech.
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study